The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
Dec. 01, 2016
Applicant:
Inspiremd, Ltd., Tel Aviv, IL;
Inventors:
Assignee:
INSPIREMD, LTD., Tel Aviv, IL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/07 (2013.01); A61F 2/90 (2013.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); A61F 2/82 (2013.01); C08G 63/00 (2006.01); C08G 63/06 (2006.01); C08G 63/08 (2006.01); C08G 63/40 (2006.01); C08G 73/02 (2006.01); C08G 79/04 (2006.01); A61F 2/00 (2006.01); A61L 31/02 (2006.01); A61L 31/04 (2006.01); A61L 31/06 (2006.01); A61L 31/10 (2006.01); A61F 2/89 (2013.01);
U.S. Cl.
CPC ...
A61F 2/90 (2013.01); A61F 2/0063 (2013.01); A61F 2/07 (2013.01); A61F 2/82 (2013.01); A61L 31/022 (2013.01); A61L 31/048 (2013.01); A61L 31/06 (2013.01); A61L 31/10 (2013.01); A61L 31/146 (2013.01); A61L 31/148 (2013.01); A61L 31/16 (2013.01); C08G 63/00 (2013.01); C08G 63/06 (2013.01); C08G 63/08 (2013.01); C08G 63/40 (2013.01); C08G 73/02 (2013.01); C08G 79/04 (2013.01); A61F 2/89 (2013.01); A61F 2002/0086 (2013.01); A61F 2002/075 (2013.01); A61F 2002/823 (2013.01); A61F 2210/0004 (2013.01); A61F 2210/0076 (2013.01); A61F 2240/001 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/604 (2013.01); A61L 2300/606 (2013.01); A61L 2420/02 (2013.01); Y10T 29/49964 (2015.01);
Abstract
Methods of providing a stent assembly that includes a stent jacket formed from an expansible mesh structure having apertures and that includes a fiber having a diameter of about 7 micrometers and about 40 micrometers, and an expansible stent operatively associated with the stent jacket. The method further comprises administering to the subject an active pharmaceutical ingredient (API) eluted from the stent assembly.